Concepedia

Barbara Leutgeb

BL

Statistics

Publications

11

Citations

1.2K

H-Index

11

Active since

2006

Affiliations

University of Cologne(Current)

University of Bonn

University Hospital Regensburg

University of Freiburg

University of Münster

Barbara Leutgeb is an author at University of Cologne specializing in oncology, medicine, and chemotherapy.

Publications per year

2006–2024

11

Publications

11

G12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertension

Angela Wirth, Zoltán Benyó, Martina Lukasova et al. · Nature Medicine · 2007 · 685 citations

Life Sciences, Molecular Biology, Physiology +16

Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O<sup>6</sup>-Methylguanine–DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial

Ulrich Herrlinger, Niklas Schäfer, Astrid Weyerbrock et al. · Journal of Clinical Oncology · 2016 · 197 citations

Medicine, Oncology, Pharmacotherapy +15

Integrin α2β1 Is Required for Regulation of Murine Wound Angiogenesis but Is Dispensable for Reepithelialization

Manon C. Zweers, Jeffrey M. Davidson, Ambra Pozzi et al. · Journal of Investigative Dermatology · 2006 · 125 citations · Full text

Life Sciences, Cell Biology, Cell Signaling +15

CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials

Neil H. Segal, Ignacio Melero, Víctor Moreno et al. · Nature Communications · 2024 · 60 citations · Full text

Medicine, Oncology, Pharmacology +17

Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial.

Ulrich Herrlinger, Niklaus Schaefer, Joachim P. Steinbach et al. · Journal of Clinical Oncology · 2013 · 29 citations

Medicine, Oncology, Pharmacotherapy +17

1–5 of 11